Biggest News Aggregation in the World
๐Ÿ“ฐ Protect Trial News

Protect Trial News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Protect Trial. Real-time updates on events, politics, business and more.

PROTECT: Teplizumab Preserves Beta-Cell Function in Newly Diagnosed Type 1 Diabetes

In the PROTECT trial, teplizumab preserved ฮฒ-cell function in newly diagnosed type 1 diabetes patients, slowing the decline of C-peptide levels, but key secondary endpoints, such as time in range and HbA1c, showed numerical trends without statistical significance.
United States Kevan Herold Leonard Thompson Yale School Of Medicine Kevin Herold Drug Administration Medicine At Yale School Of

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science